Ophthalmic Scientific Advisory Board
Penny Asbell, MD
Dr. Penny Asbell is a Professor of Ophthalmology at Mount Sinai School of Medicine and Director of the Cornea Service and Refractive Surgery Center. Dr. Asbell is currently on the Board of Directors of the International Society of Refractive Surgery and is Past-President of the Contact Lens Association of Ophthalmologists. Dr. Asbell serves on Mount Sinai's Committee on the Ethical Practices in Research and the New York County Medical Society's Special Committee on Women Physicians. Dr. Asbell received her M.D. from the State University of New York at Buffalo, interned in Internal Medicine at Yale-New Haven Hospital, then trained as a resident and fellow in Ophthalmology and Immunology at the New York University Medical Center.
Robert Ritch, MD
Dr. Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director Emeritus and Chief of Glaucoma Services at New York Eye and Ear Infirmary of Mount Sinai (NYEE). He has devoted his career to broadening our understanding of the underlying etiologies and mechanisms of glaucoma and innovation in its medical, laser, and surgical treatment. Dr. Ritch received his B.A. cum laude from Harvard College and an M.A. in cell biology from Harvard University. He received his M.D. from Albert Einstein College of Medicine and, after an internship at St. Vincent’s Medical Center and a residency in Ophthalmology at Mount Sinai School of Medicine, received fellowships in glaucoma from the Heed Foundation and the National Institutes of Health.
James T. Rosenbaum, MD
Dr. James T. Rosenbaum has spent more than 30 years studying ocular inflammatory disease including animal models of uveitis. His research interests are complemented by his direction of a clinic devoted to patients with ocular inflammatory diseases including uveitis, scleritis, orbital inflammation, and steroid sensitive optic neuropathy. He has authored more than 400 peer reviewed publications and more than 75 chapters or invited publications. He has been honored by the Association for Research in Vision and Ophthalmology and by the International Uveitis Study Group Eye Foundation with their highest awards. Dr. Rosenbaum received his medical degree from Yale Medical School in New Haven, CT. He completed his medicine residency and rheumatology fellowship at Stanford Medical Center in Stanford, CA.
News & Events
- Mitotech Completes First Patient Visit in VISTA-1 - Phase 3 Clinical Study of SkQ1 for Dry Eye Disease
- Mitotech Initiates Phase 3 Clinical Trial of SkQ1 Ophthalmic Solution in Patients with Dry Eye Disease in a Co-Development Effort with Essex Bio-Technology
- Mitotech partners with Essex Bio-Technology for a late-stage clinical program in Dry Eye Disease
- Mitotech announces new Dry Eye data set supporting SkQ1’s novel mechanism of action
- Mitotech's SkQ1 improved visual acuity in Leber's Hereditary Optic Neuropathy (LHON) patients
- Mitotech’s SkQ1 and its potential for treating age-related disorders discussed in Fierce Biotech publication
- Mitotech’s lead compound significantly increased lifespan of rapidly aging mice